“The cancer vaccines are going to have to show they can compete against [a] raising bar,” said Susan Galbraith, head of oncology research and development at AstraZeneca, which is backing CAR-T ...

The rendering shows the new Palo Alto Link shuttle ... BART and private companies such as Google and Genentech. Some will be hybrids, others will be electric vehicles. It’s our mission to ...

The BioNTech product used to treat Haycock is being co-developed with Roche subsidiary Genentech ... to show they can compete against [a] raising bar,” said Susan Galbraith, head of research and ...

For decades, the biotech company Genentech has carved out a reputation in the industry as a scientist’s paradise, a place where researchers have developed new therapies in-house and published ...

September 12, 2024--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has approved Tecentriq ...

Genentech has received Food and Drug Administration approval for its treatment of certain types of lung, liver, skin and soft tissue cancer in adults. The treatment, called Tecentriq Hybreza, can ...

Is Genentech losing its zest for innovation? Genentech has long been known for innovation, but that reputation has been questioned in the wake of multiple rounds of layoffs and the company’s ...

(KRON) — Biotech firm Genentech is laying off nearly 100 employees at its South San Francisco headquarters, according to a WARN notice from the California Employment Development Department (EDD).

Following the announcement of a large layoff round in April and a major restructuring initiative unveiled earlier this month, Genentech is sending more jobs to the chopping block. The Roche ...

Genentech, a drugmaker based in South San Francisco, is laying off 93 more local workers just months after a 436-worker cut. The company, which is owned by Swiss pharmaceutical giant Roche ...